Sanofi’s Dengue Vaccine Increases Risk Of Severe Disease Among Children Not Previously Infected, Analysis Confirms
Reuters: Study confirms higher risk of dengue in kids who got Sanofi vaccine
“An analysis of data on Sanofi’s dengue vaccine, which has been given to more than 800,000 school children in the Philippines, confirms it increases the risk of hospitalization and severe dengue in those who had never previously been infected with the mosquito-borne virus…” (Steenhuysen, 6/13).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.